These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31068788)

  • 41. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.
    Stefanescu MR; Dohnalek M; Maderwald S; Thürling M; Minnerop M; Beck A; Schlamann M; Diedrichsen J; Ladd ME; Timmann D
    Brain; 2015 May; 138(Pt 5):1182-97. PubMed ID: 25818870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viewpoint: spinocerebellar ataxias as diseases of Purkinje cell dysfunction rather than Purkinje cell loss.
    Kapfhammer JP; Shimobayashi E
    Front Mol Neurosci; 2023; 16():1182431. PubMed ID: 37426070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Mechanisms and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
    Karam A; Trottier Y
    Adv Exp Med Biol; 2018; 1049():197-218. PubMed ID: 29427104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Ataxias. Diagnostic procedure and treatment].
    Klockgether T
    Nervenarzt; 2005 Oct; 76(10):1275-83; quiz 1284-5. PubMed ID: 16175415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
    Matilla-Dueñas A; Sánchez I; Corral-Juan M; Dávalos A; Alvarez R; Latorre P
    Cerebellum; 2010 Jun; 9(2):148-66. PubMed ID: 19890685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depression and clinical progression in spinocerebellar ataxias.
    Lo RY; Figueroa KP; Pulst SM; Perlman S; Wilmot G; Gomez C; Schmahmann J; Paulson H; Shakkottai VG; Ying S; Zesiewicz T; Bushara K; Geschwind M; Xia G; Yu JT; Lee LE; Ashizawa T; Subramony SH; Kuo SH
    Parkinsonism Relat Disord; 2016 Jan; 22():87-92. PubMed ID: 26644294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocannabinoids and neurodegenerative diseases.
    Micale V; Mazzola C; Drago F
    Pharmacol Res; 2007 Nov; 56(5):382-92. PubMed ID: 17950616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spinocerebellar ataxias.
    Teive HA
    Arq Neuropsiquiatr; 2009 Dec; 67(4):1133-42. PubMed ID: 20069236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients.
    Espejo-Porras F; Fernández-Ruiz J; de Lago E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):377-386. PubMed ID: 29334787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parkinsonism & related disorders. Ataxias.
    Klockgether T
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S391-4. PubMed ID: 18267270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ca
    Hisatsune C; Hamada K; Mikoshiba K
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1733-1744. PubMed ID: 29777722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurological Disease Modelling for Spinocerebellar Ataxia Using Zebrafish.
    Namikawa K; Dorigo A; Köster RW
    J Exp Neurosci; 2019; 13():1179069519880515. PubMed ID: 31666796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dilemma of multiple system atrophy and spinocerebellar ataxias.
    Li M; Ma Q; Zhao X; Wang C; Wu H; Li J; Yang W
    J Neurol; 2018 Dec; 265(12):2764-2772. PubMed ID: 29700645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36.
    Aguiar P; Pardo J; Arias M; Quintáns B; Fernández-Prieto M; Martínez-Regueiro R; Pumar JM; Silva-Rodríguez J; Ruibal Á; Sobrido MJ; Cortés J
    Mov Disord; 2017 Feb; 32(2):264-273. PubMed ID: 27862279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autosomal dominant sensory/motor neuropathy with Ataxia (SMNA): Linkage to chromosome 7q22-q32.
    Brkanac Z; Fernandez M; Matsushita M; Lipe H; Wolff J; Bird TD; Raskind WH
    Am J Med Genet; 2002 May; 114(4):450-7. PubMed ID: 11992570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Degenerative ataxias, from genes to therapies: The 2015 Cotzias Lecture.
    Pulst SM
    Neurology; 2016 Jun; 86(24):2284-90. PubMed ID: 27298447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.
    Shuvaev AN; Hosoi N; Sato Y; Yanagihara D; Hirai H
    J Physiol; 2017 Jan; 595(1):141-164. PubMed ID: 27440721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Initial Symptom and Motor Progression in Spinocerebellar Ataxias.
    Luo L; Wang J; Lo RY; Figueroa KP; Pulst SM; Kuo PH; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind M; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Cerebellum; 2017 Jun; 16(3):615-622. PubMed ID: 27848087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.